Mersana Therapeutics, Inc. Operating Lease, Liability, Current
Mersana Therapeutics, Inc. had Operating Lease, Liability, Current of $2.29 million as of 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Notes › Leases › Assets and Liabilities, Lessee
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2025-11-14
- 2025-09-30: Operating Lease, Liability, Current $2.29M.
- 2025-06-30: Operating Lease, Liability, Current $3.27M.
- 2025-03-31: Operating Lease, Liability, Current $3.96M.
- 2024-12-31: Operating Lease, Liability, Current $3.86M.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2025-09-30 | $2.29M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $3.27M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $3.96M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $3.86M 10-Q · filed 2025-11-14 |
| 2024-09-30 | $3.75M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $3.65M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $3.55M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $3.25M 10-K · filed 2025-03-03 |
| 2023-09-30 | $3.14M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $3.02M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $2.90M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $2.80M 10-K · filed 2024-02-28 |
| 2022-09-30 | $2.70M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $2.59M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $2.40M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $2.30M 10-K · filed 2023-02-28 |
| 2021-09-30 | $2.24M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $2.17M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $1.57M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $1.44M 10-K · filed 2022-02-28 |
| 2020-09-30 | $1.28M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $1.13M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $1.15M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $2.22M 10-K · filed 2021-02-26 |
| 2019-09-30 | $2.15M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $2.07M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $2.00M 10-Q · filed 2019-05-09 |